Innoviva Analyst Ratings
Innoviva Analyst Ratings
While ratings are subjective and will change, the latest Innoviva (INVA) rating was a maintained with a price target of $13.00 to $14.00. The current price Innoviva (INVA) is trading at is $12.95, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/13/2022 | 8.11% | Morgan Stanley | $13 → $14 | Maintains | Underweight |
| 08/08/2022 | 0.39% | Morgan Stanley | $12 → $13 | Maintains | Underweight |
| 07/20/2022 | 23.55% | Goldman Sachs | → $16 | Initiates Coverage On | → Neutral |
| 07/15/2022 | -7.34% | Morgan Stanley | $13 → $12 | Maintains | Underweight |
| 04/12/2022 | 0.39% | Morgan Stanley | $12 → $13 | Maintains | Underweight |
| 02/23/2022 | -7.34% | Morgan Stanley | $10 → $12 | Maintains | Underweight |
| 02/11/2022 | 116.22% | EF Hutton | → $28 | Initiates Coverage On | → Buy |
| 11/11/2020 | -22.78% | Morgan Stanley | $8 → $10 | Maintains | Underweight |
| 06/25/2018 | — | Stifel | Terminates Coverage On | Hold → Hold | |
| 04/27/2018 | 23.55% | Stifel | $17 → $16 | Maintains | Hold |
| 11/20/2017 | 0.39% | Deutsche Bank | → $13 | Initiates Coverage On | → Hold |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 2022 年 10 月 13 日 | 8.11% | 摩根士丹利 | 13 美元 → 14 美元 | 維護 | 體重不足 |
| 08/08/2022 | 0.39% | 摩根士丹利 | 12 美元 → 13 美元 | 維護 | 體重不足 |
| 07/20/2022 | 23.55% | 高盛 | → 16 美元 | 啓動覆蓋範圍開啓 | → 中立 |
| 07/15/2022 | -7.34% | 摩根士丹利 | 13 美元 → 12 美元 | 維護 | 體重不足 |
| 04/12/2022 | 0.39% | 摩根士丹利 | 12 美元 → 13 美元 | 維護 | 體重不足 |
| 2022 年 2 月 23 日 | -7.34% | 摩根士丹利 | 10 美元 → 12 美元 | 維護 | 體重不足 |
| 2022 年 11 月 2 日 | 116.22% | EF Hutton | → 28 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 11/11/2020 | -22.78% | 摩根士丹利 | 8 美元 → 10 美元 | 維護 | 體重不足 |
| 2018 年 6 月 25 日 | — | Stifel | 終止承保範圍 | 按住 → 按住 | |
| 04/27/2018 | 23.55% | Stifel | 17 美元 → 16 美元 | 維護 | 保持 |
| 11/20/2017 | 0.39% | 德意志銀行 | → 13 美元 | 啓動覆蓋範圍開啓 | → 按住 |
Innoviva Questions & Answers
Innoviva 問題與解答
The latest price target for Innoviva (NASDAQ: INVA) was reported by Morgan Stanley on October 13, 2022. The analyst firm set a price target for $14.00 expecting INVA to rise to within 12 months (a possible 8.11% upside). 7 analyst firms have reported ratings in the last year.
摩根士丹利於2022年10月13日公佈了Innoviva（納斯達克股票代碼：INVA）的最新目標股價。該分析公司將目標股價定爲14.00美元，預計INVA將在12個月內升至12個月內（可能上漲8.11％）。去年有7家分析公司公佈了評級。
The latest analyst rating for Innoviva (NASDAQ: INVA) was provided by Morgan Stanley, and Innoviva maintained their underweight rating.
摩根士丹利對Innoviva（納斯達克股票代碼：INVA）的最新分析師評級由摩根士丹利提供，Innoviva維持其減持評級。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Innoviva, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Innoviva was filed on October 13, 2022 so you should expect the next rating to be made available sometime around October 13, 2023.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與Innoviva的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級，因此每家公司每年應該獲得4次評級。Innoviva的最新評級是在2022年10月13日發佈的，因此您應該預計下一個評級將在2023年10月13日左右公佈。
While ratings are subjective and will change, the latest Innoviva (INVA) rating was a maintained with a price target of $13.00 to $14.00. The current price Innoviva (INVA) is trading at is $12.95, which is out of the analyst's predicted range.
儘管評級是主觀的，並且會發生變化，但最新的Innoviva（INVA）評級保持不變，目標股價爲13.00美元至14.00美元。Innoviva（INVA）目前的交易價格爲12.95美元，超出了分析師的預期區間。
